The National Cancer Institute (NCI) awarded a $169,932 Project Grant under the Cancer Biology Research program (CFDA 93.396) to The Trustees of Columbia University in the City of New York to advance proteomics technologies for cancer research. The grant will enable the university's Proteomics and Macromolecular Crystallography Shared Resource (PMCSR) to further enhance its capabilities, including automating deep proteomic profiling of biofluids, developing comprehensive pipelines for immunopeptidomics and cell surfaceome profiling, and implementing lab automation. These technological advancements are expected to significantly impact cancer studies, leading to novel discoveries, high-impact publications, and additional funding. The award provides career stability to the technical director of the PMCSR, who has co-authored 47 peer-reviewed articles in the past five years and plans to continue serving the cancer research community through this project from September 2024 to July 2029.
Generated 1/28/25, 8:20 AM